{
    "root": "0dcf2f70-92d9-c24b-9787-0d395e04b46f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "SEMGLEE",
    "value": "20250303",
    "ingredients": [
        {
            "name": "INSULIN GLARGINE",
            "code": "2ZM8CX04RZ"
        },
        {
            "name": "ZINC CHLORIDE",
            "code": "86Q357L16B"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "METACRESOL",
            "code": "GGO4Y809LO"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "POLYSORBATE 20",
            "code": "7T1F30V5YH"
        }
    ],
    "indications": "SEMGLEE is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.\n                  \n                     Limitations of Use \n                  \n                  SEMGLEE is not recommended for the treatment of diabetic ketoacidosis.",
    "contraindications": "Individualize dosage based on metabolic needs, blood glucose monitoring, glycemic control, type of diabetes, and prior insulin use. ( 2.2 ) Administer subcutaneously into the abdominal area, thigh, or deltoid once daily at any time of day, but at the same time every day. ( 2.1 ) Do not dilute or mix with any other insulin or solution. ( 2.1 ) Rotate injection sites to reduce risk of lipodystrophy and localized cutaneous amyloidosis. ( 2.1 ) See Full Prescribing Information for the recommended starting dosage in patients with type 2 diabetis ( 2.3 ) and how to change to SEMGLEE from other insulins. ( 2.4 ) Closely monitor glucose when switching to SEMGLEE and during initial weeks thereafter. ( 2.4 )",
    "warningsAndPrecautions": null,
    "adverseReactions": "SEMGLEE is contraindicated: \n                  \n                     \n                        •During episodes of hypoglycemia [see Warnings and Precautions (5.3)]. \n                     \n                     \n                        •In patients with hypersensitivity to insulin glargine products or any of the excipients in SEMGLEE [see Warnings and Precautions (5.5)]."
}